Literature DB >> 15760304

Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.

Yasuo Okamoto1, Jun Morishita, Jun Wang, Patricia C Schmid, Randy J Krebsbach, Harald H O Schmid, Natsuo Ueda.   

Abstract

In animal tissues, NAEs (N-acylethanolamines), including N-arachidonoylethanolamine (anandamide), are primarily formed from their corresponding NAPEs (N-acylphosphatidylethanolamines) by a phosphodiesterase of the PLD (phospholipase D) type (NAPE-PLD). Recently, we cloned cDNAs of NAPE-PLD from mouse, rat and human [Okamoto, Morishita, Tsuboi, Tonai and Ueda (2004) J. Biol. Chem. 279, 5298-5305]. However, it remained unclear whether NAPE-PLD acts on endogenous NAPEs contained in the membrane of living cells. To address this question, we stably transfected two mammalian cell lines (HEK-293 and CHO-K1) with mouse NAPE-PLD cDNA, and investigated the endogenous levels and compositions of NAPEs and NAEs in these cells, compared with mock-transfected cells, with the aid of GC-MS. The overexpression of NAPE-PLD caused a decrease in the total amount of NAPEs by 50-90% with a 1.5-fold increase in the total amount of NAEs, suggesting that the recombinant NAPE-PLD utilizes endogenous NAPE as a substrate in the cell. Since the compositions of NAEs and NAPEs of NAPE-PLD-overexpressing cells and mock-transfected cells were very similar, the enzyme did not appear to discriminate among the N-acyl groups of endogenous NAPEs. These results confirm that overexpressed NAPE-PLD is capable of forming NAEs, including anandamide, in living cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760304      PMCID: PMC1184557          DOI: 10.1042/BJ20041790

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 2.  N-Acylethanolamines and precursor phospholipids - relation to cell injury.

Authors:  H S Hansen; B Moesgaard; H H Hansen; G Petersen
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

3.  N-Acylethanolamine accumulation in infarcted myocardium.

Authors:  D E Epps; P C Schmid; V Natarajan; H H Schmid
Journal:  Biochem Biophys Res Commun       Date:  1979-09-27       Impact factor: 3.575

4.  Properties of rat liver N-acylethanolamine amidohydrolase.

Authors:  P C Schmid; M L Zuzarte-Augustin; H H Schmid
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

5.  Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations.

Authors:  V Natarajan; P C Schmid; P V Reddy; M L Zuzarte-Augustin; H H Schmid
Journal:  J Neurochem       Date:  1983-11       Impact factor: 5.372

6.  Catabolism of N-acylethanolamine phospholipids by dog brain preparations.

Authors:  V Natarajan; P C Schmid; P V Reddy; H H Schmid
Journal:  J Neurochem       Date:  1984-06       Impact factor: 5.372

7.  N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain.

Authors:  V Natarajan; P C Schmid; H H Schmid
Journal:  Biochim Biophys Acta       Date:  1986-08-14

8.  Hydrolysis of N-acylated glycerophospholipids by phospholipases A2 and D: a method of identification and analysis.

Authors:  P C Schmid; V Natarajan; B K Weis; H H Schmid
Journal:  Chem Phys Lipids       Date:  1986 Oct-Nov       Impact factor: 3.329

9.  N-Acylation of ethanolamine phospholipids in canine myocardium.

Authors:  V Natarajan; P V Reddy; P C Schmid; H H Schmid
Journal:  Biochim Biophys Acta       Date:  1982-08-18

10.  Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type.

Authors:  P C Schmid; P V Reddy; V Natarajan; H H Schmid
Journal:  J Biol Chem       Date:  1983-08-10       Impact factor: 5.157

View more
  11 in total

1.  Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.

Authors:  Lilu Guo; Stephen D Gragg; Zhongyi Chen; Yongqin Zhang; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2013-09-09       Impact factor: 5.922

2.  Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD).

Authors:  Beatrice Castellani; Eleonora Diamanti; Daniela Pizzirani; Piero Tardia; Martina Maccesi; Natalia Realini; Paola Magotti; Gianpiero Garau; Thomas Bakkum; Silvia Rivara; Marco Mor; Daniele Piomelli
Journal:  Chem Commun (Camb)       Date:  2017-11-28       Impact factor: 6.222

3.  A biosynthetic pathway for anandamide.

Authors:  Jie Liu; Lei Wang; Judith Harvey-White; Douglas Osei-Hyiaman; Raj Razdan; Qian Gong; Andrew C Chan; Zhifeng Zhou; Bill X Huang; Hee-Yong Kim; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

4.  Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family.

Authors:  Toru Uyama; Natsuki Ikematsu; Manami Inoue; Naoki Shinohara; Xing-Hua Jin; Kazuhito Tsuboi; Takeharu Tonai; Akira Tokumura; Natsuo Ueda
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

5.  Parathyroid hormone stimulates phosphatidylethanolamine hydrolysis by phospholipase D in osteoblastic cells.

Authors:  Amareshwar T K Singh; Michael A Frohman; Paula H Stern
Journal:  Lipids       Date:  2005-11       Impact factor: 1.880

6.  Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids.

Authors:  Donmienne Leung; Alan Saghatelian; Gabriel M Simon; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

Review 7.  Lipidomic analysis of endocannabinoid metabolism in biological samples.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-01-14       Impact factor: 3.205

8.  Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction.

Authors:  Daniela Wenzel; Michaela Matthey; Laura Bindila; Raissa Lerner; Beat Lutz; Andreas Zimmer; Bernd K Fleischmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

9.  Multiple pathways involved in the biosynthesis of anandamide.

Authors:  Jie Liu; Lei Wang; Judith Harvey-White; Bill X Huang; Hee-Yong Kim; Serge Luquet; Richard D Palmiter; Gerald Krystal; Ravi Rai; Anu Mahadevan; Raj K Razdan; George Kunos
Journal:  Neuropharmacology       Date:  2007-06-06       Impact factor: 5.250

10.  Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity.

Authors:  David M Mofford; Spencer T Adams; G S Kiran Kumar Reddy; Gadarla Randheer Reddy; Stephen C Miller
Journal:  J Am Chem Soc       Date:  2015-07-02       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.